{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:01Z","timestamp":1791828541484,"version":"4.3.4"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["305373"],"award-info":[{"award-number":["305373"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is a disorder of adrenal steroid biosynthesis, leading to hypocortisolism, hypoaldosteronism, and hyperandrogenism. Impaired quality of life (QoL) has been demonstrated in women with CAH, but data on men with CAH are scarce. We hypothesized that disease severity and poor treatment control are inversely associated with QoL. In this study, 109 men (16-68 years) with 21OHD were included. The WHOQOL-BREF questionnaire was used to measure self-reported QoL domain scores on a 0-100 scale, where higher scores reflect better QoL. QoL domain scores were compared to published data on healthy and chronically ill reference populations from France, Germany, the Netherlands, and the United Kingdom. Differences in QoL scores among groups of disease severity and treatment control were tested within the study population. Overall, the men with CAH in this study appeared to rate their QoL as good. Median domain scores were 78.6 (IQR: 67.9-85.7) for physical health, 79.2 (IQR: 66.7-87.5) for psychological health, 75.0 (IQR: 58.3-83.3) for social relationships, and 81.3 (IQR: 71.9-90.6) for environment. In general, these scores were similar to WHOQOL-BREF domain scores in healthy references and higher compared to chronically ill reference populations. The domain scores did not differ among genotype groups, but patients with undertreatment or increased 17-hydroxyprogestrone concentrations scored higher on several QoL domains (p&amp;lt;0.05). Patients treated with dexamethasone or prednisone scored higher on the physical health, psychological health, and social relationships domains, but not on the environmental domain. In conclusion, QoL domain scores appeared to be comparable to healthy reference populations and higher compared to patients with a chronic illness. QoL was not influenced by genotype, but undertreatment and use of dexamethasone or prednisone were associated with higher QoL.<\/jats:p>","DOI":"10.3389\/fendo.2021.626646","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T14:06:37Z","timestamp":1616162797000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency"],"prefix":"10.3389","volume":"12","author":[{"given":"Myrthe J. M.","family":"Verhees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Span","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred C. G. J.","family":"Sweep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonius E.","family":"van Herwaarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nordenstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma A.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Richter-Unruh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bouvattier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude Brac de la","family":"Perri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nike M. M. L.","family":"Stikkelbroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nel","family":"Roeleveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedi L.","family":"Claahsen-van der Grinten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"95","author":"Speiser","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000327794","article-title":"Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"76","author":"Reisch","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.21.3.0398","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-011-9591-x","article-title":"Clinical outcomes in the management of congenital adrenal hyperplasia","volume":"41","author":"Falhammar","year":"2012","journal-title":"Endocrine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3326","article-title":"Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden","volume":"99","author":"Strandqvist","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12572","article-title":"Quality of life in a large cohort of adult Brazilian patients with 46,XX and 46,XY disorders of sex development from a single tertiary centre","volume":"82","author":"Cassia Amaral","year":"2015","journal-title":"Clin Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0284","article-title":"Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway","volume":"163","author":"Nermoen","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2010.03920.x","article-title":"Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency","volume":"74","author":"Reisch","year":"2011","journal-title":"Clin Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12020-013-0161-2","article-title":"Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia","volume":"47","author":"Falhammar","year":"2014","journal-title":"Endocrine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2000.tb01213.x","article-title":"Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life","volume":"89","author":"Jaaskelainen","year":"2000","journal-title":"Acta Paediatr (Oslo Norway: 1992)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12020-018-1723-0","article-title":"Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review","volume":"62","author":"Daae","year":"2018","journal-title":"Endocrine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12902-017-0198-y","article-title":"Participation of adults with disorders\/differences of sex development (DSD) in the clinical study dsd-LIFE: design, methodology, recruitment, data quality and study population","volume":"17","author":"Rohle","year":"2017","journal-title":"BMC Endocr Disord"},{"key":"B15","article-title":"Division of Mental Health","year":"1996"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0862","article-title":"Gonadal function in adult male patients with congenital adrenal hyperplasia","volume":"178","author":"Engels","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.10.014","article-title":"Genetics of congenital adrenal hyperplasia","volume":"23","author":"Krone","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B18","article-title":"Appendix A1 Education","year":"2018"},{"key":"B19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12955-018-0881-3","article-title":"Multicentre cross-sectional clinical evaluation study about quality of life in adults with disorders\/differences of sex development (DSD) compared to country specific reference populations (dsd-LIFE)","volume":"16","author":"Rapp","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2009.10.009","article-title":"The WHOQOL-BREF questionnaire: French adult population norms for the physical health, psychological health and social relationship dimensions","volume":"58","author":"Baumann","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"key":"B21","article-title":"WHOQOL \u2013 100 und WHOQOL \u2013 BREF. Handbuch f\u00fcr die deutschsprachige Version der WHO Instrumente zur Erfassung der Lebensqualit\u00e4t","volume-title":"G\u00f6ttingen: Hogrefe- Verlag","author":"Angermeyer","year":"2000"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/j.1440-1614.2006.01799.x","article-title":"Quality of life and psychopathology: investigations into their relationship","volume":"40","author":"Masthoff","year":"2006","journal-title":"Aust N Z J Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1369-7625.2010.00650.x","article-title":"Expecting a good quality of life in health: assessing people with diverse diseases and conditions using the WHOQOL-BREF","volume":"15","author":"Skevington","year":"2012","journal-title":"Health Expect: Int J Public Participation Health Care Health Policy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.05.004","article-title":"Congenital adrenal hyperplasia\u2013pharmacologic interventions from the prenatal phase to adulthood","volume":"132","author":"Claahsen-van der Grinten","year":"2011","journal-title":"Pharmacol Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.01.023","article-title":"A physiatrist\u2019s view of response shift","volume":"62","author":"van Rijn","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3707","article-title":"Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","article-title":"The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group","volume":"13","author":"Skevington","year":"2004","journal-title":"Qual Life Res: Int J Qual Life Asp Treat Care Rehabil"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1087","article-title":"Adrenal Steroid Metabolites Accumulating in Congenital Adrenal Hyperplasia Lead to Transactivation of the Glucocorticoid Receptor","volume":"156","author":"Pijnenburg-Kleizen","year":"2015","journal-title":"Endocrinology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01139","article-title":"Reduced Frequency of Biological and Increased Frequency of Adopted Children in Males With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study","volume":"102","author":"Falhammar","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0128","article-title":"Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE)","volume":"168","author":"Han","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00547","article-title":"Glucocorticoid Activity of Adrenal Steroid Precursors in Untreated Patients With Congenital Adrenal Hyperplasia","volume":"104","author":"Engels","year":"2019","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.626646\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T14:06:40Z","timestamp":1616162800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.626646\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":31,"alternative-id":["10.3389\/fendo.2021.626646"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.626646","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"article-number":"626646"}}